Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma - Hlavac, M; Dwucet, A; Westhoff, A; Kast, RE; Engelke, J; Siegelin, MD; Wirtz, CR; Halatsch, ME; Karpel-Massler, G (Klinische Pädiatrie, 2018)